Effects of Roux-en-Y gastric bypass and sleeve gastrectomy on β-cell function at one year after surgery: a systematic review.

Bariatric surgery is a highly effective obesity treatment resulting in substantial weight loss and improved glucose metabolism. We hereby aimed to summarize available evidence of the effect of the two most common bariatric surgery procedures, Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG), on dynamic measures of β-cell function (BCF). A systematic search of the literature was conducted in 3 bibliographic databases for studies reporting effects of RYGB and/or SG on BCF assessed using dynamic metabolic perturbation (oral or intravenous bolus stimulation), performed before and 1 year (± 3 months) after surgery. Twenty-seven unique studies (6 randomized controlled trials and 21 observational studies), involving a total of 1,856 obese adults were included for final analysis. 25 and 9 studies report effects of RYGB and SG on BCF respectively (7 studies compared the two procedures). 7 studies report results according to pre-surgical diabetic status. Owing to variable testing procedures and BCF indices reported, no meta-analysis was feasible, and data were summarized qualitatively. For both surgical procedures, most studies suggest an increase in BCF and disposition index, particularly when using oral stimulation, with a more pronounced increase in diabetic than non-diabetic individuals. Additionally, limited indications for greater effects after RYGB and SG was found. The quality of the included studies was in general satisfactory. The considerable heterogeneity of test protocols and outcome measures underscores the need for a harmonization of BCF testing in future research

Interleaved trinuclear MRS for single-session investigation of carbohydrate and lipid metabolism in human liver at 7T.

The liver plays a central role in metabolic homeostasis, as exemplified by a variety of clinical disorders with hepatic and systemic metabolic disarrays. Of particular interest are the complex interactions between lipid and carbohydrate metabolism in highly prevalent conditions such as obesity, diabetes, and fatty liver disease. Limited accessibility and the need for invasive procedures challenge direct investigations in humans. Hence, noninvasive dynamic evaluations of glycolytic flux and steady-state assessments of lipid levels and composition are crucial for basic understanding and may open new avenues toward novel therapeutic targets. Here, three different MR spectroscopy (MRS) techniques that have been combined in a single interleaved examination in a 7T MR scanner are evaluated. 1 H-MRS and 13 C-MRS probe endogenous metabolites, while deuterium metabolic imaging (DMI) relies on administration of deuterated tracers, currently 2 H-labelled glucose, to map the spatial and temporal evolution of their metabolic fate. All three techniques have been optimized for a robust single-session clinical investigation and applied in a preliminary study of healthy subjects. The use of a triple-channel 1 H/2 H/13 C RF coil enables interleaved examinations with no need for repositioning. Short-echo-time STEAM spectroscopy provides well resolved spectra to quantify lipid content and composition. The relative benefits of using water saturation versus metabolite cycling and types of respiratory synchronization were evaluated. 2 H-MR spectroscopic imaging allowed for registration of time- and space-resolved glucose levels following oral ingestion of 2 H-glucose, while natural abundance 13 C-MRS of glycogen provides a dynamic measure of hepatic glucose storage. For DMI and 13 C-MRS, the measurement precision of the method was estimated to be about 0.2 and about 16 mM, respectively, for 5 min scanning periods. Excellent results were shown for the determination of dynamic uptake of glucose with DMI and lipid profiles with 1 H-MRS, while the determination of changes in glycogen levels by 13 C-MRS is also feasible but somewhat more limited by signal-to-noise ratio

Effects of Roux-en-Y gastric bypass and sleeve gastrectomy on β-cell function at one year after surgery: a systematic review

Bariatric surgery is a highly effective obesity treatment resulting in substantial weight loss and improved glucose metabolism. We hereby aimed to summarize available evidence of the effect of the two most common bariatric surgery procedures, Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG), on dynamic measures of β-cell function (BCF). A systematic search of the literature was conducted in 3 bibliographic databases for studies reporting effects of RYGB and/or SG on BCF assessed using dynamic metabolic perturbation (oral or intravenous), performed before and 1 year (± 3 months) after surgery. Twenty-seven unique studies (6 randomized controlled trials and 21 observational studies), involving a total of 1,856 obese adults were included for final analysis. 25 and 9 studies report effects of RYGB and SG on BCF respectively (7 studies compared the two procedures). 7 studies report results according to pre-surgical diabetic status. Owing to variable testing procedures and BCF indices reported, no meta-analysis was feasible, and data were summarized qualitatively. For both surgical procedures, most studies suggest an increase in BCF and disposition index, particularly when using oral stimulation, with a more pronounced increase in diabetic than non-diabetic individuals. Additionally, limited indications for greater effects after RYGB and SG was found. The quality of the included studies was in general of satisfactory. The considerable heterogeneity of test protocols and outcome measures underscores the need for a harmonization of BCF testing in future research